🔎 Trials Near Me

Home › Cancer (all types) › Indiana

Cancer (all types) clinical trials in Indiana

31 studies for Cancer (all types) are looking for participants at sites in Indiana.

Cities in Indiana

Daily Hand-Held Vibration Therapy

  • Indiana University Health West, Avon
  • Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
  • IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT04207437

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07566156

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • Indiana University, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • Franciscan Health Oncology and Hematology Specialists, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Franciscan St. Francis Health /ID# 279788, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Community Health Network, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • IN Univ Simon Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

  • Indiana University - Purdue, Indianapolis
RecruitingObservational study
2 Months · All sexes · Updated Sep 16, 2026 · NCT00900198

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07169851

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • Franciscan Health, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05335928

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • IU Health North Hospital, Carmel
  • Northwest Cancer Center - Crown Point, Crown Point
  • UChicago Medicine Northwest Indiana, Crown Point
  • and 13 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

  • Parkview Research Center, Fort Wayne
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 28, 2026 · NCT07022483

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Fort Wayne Medical Oncology And Hematology /ID# 268179, Fort Wayne
  • Franciscan St. Francis Health /ID# 280928, Indianapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05650632

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05852717

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

  • Indiana University School of Medicine, Indianapolis
RecruitingHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Jun 24, 2026 · NCT05346796

Childhood Cancer Survivor Study

  • Indiana University/Riley Hospital for Children, Indianapolis
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jun 17, 2026 · NCT01120353

Galleri® in the Medicare Population.

  • Community Health Network Anderson, Anderson
  • Community Health Network North, Fishers
  • Community Health Network East, Indianapolis
  • and 3 more
RecruitingHealthy volunteers welcome
Ages 50 and older · All sexes · Updated May 22, 2026 · NCT05673018

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

  • GSK Investigational Site, Fort Wayne
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06551142

The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities

  • University Hospital Clinical Research Center, Indianapolis
  • Purdue Clinical Research Center, West Lafayette
Recruiting
Ages 45 to 75 · All sexes · Updated May 14, 2026 · NCT07086833

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

  • Goshen Center for Cancer Care, Goshen
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Feb 24, 2026 · NCT06207032

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761

GEMINI-NSCLC: NSCLC Biomarker Study

  • Community Health Network, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

  • IU Simon Comprehensive Cancer Center, Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 18, 2025 · NCT05970497

Addressing Tetrachloroethylene Exposure in an Impacted Community

  • Purdue University, West Lafayette
Recruiting
Ages 18 to 99 · All sexes · Updated Mar 18, 2025 · NCT05819996

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

  • Community Health Network, Inc., Indianapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.